Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 78, Issue 1, 2008, Pages 21-26

  Louw, L ^a   Claassen, J ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; ESSENTIAL FATTY ACID; FATTY ACID; PROTEIN BCL 2; TOBACCO SMOKE;

ALCOHOL ABUSE; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOGENESIS; DIET SUPPLEMENTATION; EARLY CANCER; ENZYME ACTIVITY; FATTY ACID METABOLISM; HUMAN; LARYNX CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; RESPIRATORY BURST; SQUAMOUS CELL CARCINOMA; WART VIRUS;

APOPTOSIS; ARACHIDONIC ACID; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CYCLOOXYGENASE 2; FATTY ACIDS; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROTO-ONCOGENE PROTEINS C-BCL-2;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

EID: 38049080606     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.10.007     Document Type: Article

References (71)

1. Almadori G., Bussu F., Cadoni G., Galli J., Rigante M., Artuso A., and Maurizi M. Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review. Eur. J. Cancer 40 (2004) 2383-2388
2. Zatonski W., Becher H., Lissowska J., and Wahrendorf J. Tobacco, alcohol and diet in the etiology of laryngeal cancer: a population based case control study. Cancer Causes Control 2 (1991) 3-10
3. Freudenheim J.L., Graham S., Byers T.E., Marshall J.R., Haughey B.P., Swanson M.K., and Wilkinson G. Diet, smoking and alcohol in cancer of the larynx: a case control study. Nutr. Cancer 17 (1992) 33-45
4. Zheng W., Blot W.J., Shu X.O., Gao Y.T., Ji B.T., Ziegler R.G., and Fraumeni F.J. Diet and other risk factors for laryngeal cancer in Shangai. Am. J. Epidemiol. 2 (1992) 178-191
5. Esteve J., Riboli E., Pequignot G., Terracini B., Merletti F., Crosignani P., Ascunce N., Zubiri L., Blanchet F., Raymond L., Repetto F., and Tuyns A.J. Diet and cancers of the larynx and hypopharynx: the IARC multi-center study in South Western Europe. Cancer Causes Control 7 (1996) 240-252
6. Riboli E., Kaaks R., and Esteve J. Nutrition and laryngeal cancer. Cancer Causes Control 7 (1996) 147-156
7. Russo A., Crosignani P., and Berrino F. Tobacco smoking, alcohol drinking and dietary factors as determinants of new primaries among male laryngeal cancer patients: a case-cohert study. Tumori 82 (1996) 519-525
8. Maier H., and Tisch M. Epidemiology of laryngeal cancer: results of the Heidelberg case control study. Acta Otolaryngol. 527 (1997) 160-164
9. Oreggia F., De Stefani E., Bofetta P., Brennan P., Deneo-Pellegrini H., and Ronco A.L. Meat, fat and risk of laryngeal cancer: a case-control study in Uruguay. Oral Oncol. 37 (2001) 141-145
10. Bosetti C., La Vecchia C., Talamini R., Negri E., Levi F., Fryzek J., McLaughlin J.K., Garavello W., and Franceschi S. Energy, macronutrients and laryngeal cancer. Ann. Oncol. 14 (2003) 907-912
11. Gallus S., Bosetti C., Franceshi S., Levi F., Negri E., and La Vecchia C. Laryngeal cancer in woman: tobacco, alcohol, nutritional and hormonal factors. Cancer Epidemiol. Biomarkers Rev. 12 (2003) 514-517
12. Morshed K., Korobowicz E., Szymanski M., Skomra D., and Cobek W. Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 262 (2005) 917-920
13. Du J., Chen G.G., Vlantis A.C., Xu H., Tsang K.Y., and van Hasselt A.C. The nuclear localization of NF-κβ and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma. J. Histochem. Cytochem. 51 (2003) 533-539
14. Taysi S., Uslu C., Akcay F., and Sutbeyaz M.Y. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg. Today 33 (2003) 651-654
15. Vineis P., Airoldi l., Veglia F., Olgiati L., Pastorelli R., Autrup H., et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and newer smokers in the EPIC prospective study. Br. Med. J. 330 (2005) 265-266
16. Horrobin D.F. Medical uses of essential fatty acids. Vet. Dermatol. 4 (1994) 161-166
17. de Pablo M.A., Puertollano M.A., and de Cienfuegos G.A. Biological and clinical significance of lipids as modulators of immune system functions. Clin. Diag. Lab. Immunol. (2002) 945-950
18. Llor X., Pons E., Roca A., Alvarez M.M., Mane J., Fernandez-Barnares F., and Gassull M.A. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin. Nutr. 22 (2003) 71-79
19. Larsson S.C., Kumlin M., Ingelman-Sundberg M., and Wolk A. Dietary long chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79 (2004) 935-945
20. Louw L., and Claassen A.J. A clinically relevant lipid model for laryngeal squamous cell carcinoma. In: Huang Y.S., Yanagita T., and Knapp H.R. (Eds). Dietary Fats and Risks of Chronic Disease (2006), AOCS Press, Champaing, IL 42-56
21. Zurier B. Essential fatty acids and inflammation. Ann. Rheum. Disease 50 (1991) 745-746
22. Lee J.-K., Sohn K.-H., Rhee S.-H., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 (2001) 16683-16689
23. Ranelletti F.O., Almadori G., Rocca B., Ciabattoni G., Habib A., Galli J., Maggiano N., Gessi M., and Lauriola L. Prognostic significance of cyclo-oxygenase in laryngeal squamous cell carcinoma. Int. J. Cancer 95 (2001) 343-349
24. Nix P., Lind M., Greenman J., Stafford N., and Cawkwell L. Expresssion of COX-2 protein in radioresistant laryngeal cancer. Ann. Oncol. 15 (2004) 797-801
25. Nix P., Cawkwell L., Patmore H., Greenman J., and Stafford N. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br. J. Cancer 20 (2005) 2185-2189
26. Ogawa T., Shiga K., Tateda M., Saijo S., Suzuki T., Miyagi H., and Kobayashi T. Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment. Oncol. Rep. 10 (2003) 1416-1461
27. Erikson J.G., Buffa F.M., Alsner J., Steiniche T., Bentzen S.M., and Overgaard J. Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother. Oncol. 72 (2004) 275-282
28. Almadori G., Busso F., Cadoni G., Galli J., Paludetti G., and Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur. J. Cancer (2005) 683-693
29. Vlachtsis K., Nikolaou A., Markou K., Fountzillas G., and Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur. Arch. Otorhinolaryngol. 262 (2005) 890-898
30. Pégorier J.P., Le May C., and Girard J. Control of gene expression by fatty acids. J. Nutr. 134 (2004) 2444S-2449S
31. Roche H.M. Dietary lipids and gene expression. Biochem. Soc. Trans. 32 (2004) 999-1002
32. Sampath H., and Ntambi J.M. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Ann. Rev. Nutr. 25 (2005) 317-340
33. Louw L. Keloids in rural black South Africans: dietary fatty acid intake and total phospholipid fatty acid blood analyses of keloid patients. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 247-253
34. Louw L. Keloids in rural black South Africans: a lipid model for the prevention and treatment of keloid formations. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 255-262
35. Louw L., Engelbrecht A.-M., and Cloete F. Comparison of the fatty acid composition in intraepithelial and infiltrating lesions of the cervix: I, Total fatty acid profiles. Prostaglandins Leukot. Essent. Fatty Acids 59 (1998) 253-257
36. Louw L., Engelbrecht A.-M., and Cloete F. Comparison of the fatty acid composition in intraepithelial and infiltrating lesions of the cervix: II. Free fatty acid profiles. Prostaglandins Leukot. Essent. Fatty Acids 59 (1998) 253-257
37. Louw L., Engelbrecht A.-M., and Cloete F. Comparison of the fatty acid compositions in intraepithelial and infiltrating lesions of the cervix: III. Saturated and unsaturated fatty acid profiles. Prostaglandins Leukot. Essent. Fatty Acids 59 (1998) 259-264
38. Das U.N. Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals. Prostaglandins Leukot. Essent. Fatty Acids 44 (1999) 201-210
39. Yaqoob P. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol. 24 (2003) 639-645
40. Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Sem. Cancer Biol. 16 (2006) 80-88
41. Tsan M.-F. Toll-like receptors, inflammation and cancer. Sem. Cancer Biol. 16 (2006) 32-37
42. Sawatsubashi M., Yamada T., Fukushima N., Mizokami H., Tokunaga O., and Shin T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 436 (2000) 243-248
43. Franchi A., Gallo O., Paglierani M., Sardi I., Mgnelli L., Masini E., and Santucci M. Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Head Neck 24 (2002) 16-23
44. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
45. Chen G.G., Lee J.F., Wang S.H., Chan U.P., Ip P.C., and Lau W.Y. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Blc-2 and NF-kappa B in human colon cancer. Life Sci. 70 (2002) 2631-2646
46. Demiral A.N., Sarioglu S., Birlik B., Sen M., and Kinay M. Prognostic significance of EGF receptor expression in early glottic cancer. Auris Nasus Larynx 31 (2004) 417-424
47. Shishodia S., and Aggarwal B.B. Nuclear factor-kappa B: a friend or a foe in cancer?. Biochem. Pharmacol. (2004) 1071-1080
48. Du J., Chen G.G., Vlantis A.C., Chan P.K.S., Tsang R.K.Y., and van Hasselt C.A. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bax and increase Bcl-2 expression. Cancer Lett. 205 (2004) 81-88
49. Pivot X., Magne N., Guardiola E., Poissonnet G., Dassonville O., Francoual M., Formento J.-L.R.-J., Bensadoun F., Dermard M., Schneider M., and Milano G. Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol. 41 (2005) 320-327
50. Chen G., Liu Y., Wang J., Luo L., Chen P., Ding J., and Gong S. Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance. Huazhong. Univ. Sci. Technol. Med. Sci. 26 (2006) 105-107
51. Lee B.J., Wang S.G., Roh H.J., Goh E.K., Chon K.M., and Park D.Y. Changes in expression of p53, proliferating cell nuclear antigen and Bcl-2 in recurrent laryngeal cancer radiotherapy. J. Laryngol. Otol. 120 (2006) 579-582
52. Redondo M., Esteban F., Gonzalez-Moles M.A., Delgado-Rodriques M., Nevado M., and Torres-Munoz J.E. Expression of the anti-apoptotic proteins clusterin and Bcl-2 in laryngeal squamous cell carcinomas. Tumor Biol. 27 (2006) 195-200
53. Okajuma H. Is the excess linoleic acid syndrome confined to Japan?. ISSFAL Newslett. 5 (1998) 3-8
54. Inci E., Civelek S., Seven A., Inci F., Korkut N., and Burcax G. Laryngeal cancer: in relation to oxidative stress. Tohoku J. Exp. Med. 200 (2003) 17-23
55. Menendez J.A., Colomer R., and Lupu R. Why does tumor-associated fatty acid synthase ignore dietary fatty acids. Med. Hypoth. 64 (2005) 342-349
56. Shah U.S., Dhir R., Gollin S.M., Chandran U.R., Lewis D., Acquafondata M., and Pflug B.R. Fatty acid synthase gene over expression and copy number in prostate adenocarcinoma. Human Pathol. 37 (2006) 401-409
57. Kawata R., Hyo S., Maeda T., Urade Y., and Takenaka H. Simultaneous expression of cyclooxygenase and microsomal prostaglandin E synthase in squamous cell carcinoma of the larynx. Acta Otolaryngol. 126 (2006) 232-627
58. Conklin K.A. Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern. Med. Rev. 7 (2002) 4-21
59. Swamy M.W., Cooma I., Patlolla J.M.R., Simi B., Bandaru S., and Chinthalapally V.R. Modulation of cyclooxygenase -2 activities by the combined action of celecoxib and docosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Mol. Can. Therapeut. 3 (2004) 215-221
60. Geleijnse J.M., Brouwer I.A., and Feskens E.J. Risks and benefits of omega-3 fats: health benefits of omega-3 fats are in doubt. Br. Med. J. 332 (2006) 915-916
61. Denys A., Hichami A., and Kahn N.A. Eicosapentaenoic acic and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. J. Lipid Res. 42 (2001) 2015-2020
62. Verlengia R., Gorjao R., Kanunfre C.C., Bordin S., De Lima T.M., Martins E.F., and Curi R. Comparative effects of eiscosapentaenoic acid and docosahexaenoic acid on proliferation, cytokine production, and pleitropic gene expression in Jukart cells. J. Nutr. Biochem. 15 (2004) 657-665
63. Courtney E.D., Matthews S., Finlayson C., Di Piwerro D., Belluzzi A., Roda E., Kang J.Y., and Leisester R.J. Eicosapentaenoic (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic adenomas. Int. J. Colorectal Disease 22 (2007) 745-746
64. Bassaganya-Rierra J., Hontecillas R., Zimmerman D.R., and Wannemuehler M.J. Dietary conjugated linoleic acid modulates phenotype and effector functions of porcine CD8+ lymphocytes. J. Nutr. 131 (2001) 2370-2377
65. Bassaganya-Riera J., Progranichniy R.M., Jobgen S.C., Halbur P.G., Yoon K.-J., O'Shea M., Mohede I., and Hontecillas R. Conjugated linoleic acid ameliorates viral infectivity in pig model of virally induced immunosuppression. J. Nutr. 133 (2003) 3204-3214
66. O'Shea M., Bassaganya-Riera J., and Mohede I.C.M. Immunomodulatory properties of conjugated linoleic acid. Am. J. Clin. Nutr. 79 (2004) 1199S-1206S
67. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. Am. J. Clin. Nutr. 79 (2004) 1132S-11326S
68. Tricon S., Burge G., Kew S., Banerjee T., Russel J.J., Grimble R.F., Williams C.M., Calder P.C., and Yaqoob P. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am. J. Clin. Nutr. 80 (2004) 1626-1633
69. Bassaganya-Riera J., and Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin. Nutr. 25 (2006) 454-465
70. Holsinger F.C., Funck E., Roberts D.B., and Diaz E.M. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck 28 (2006) 779-784
71. Holsinger F.C., and Diaz Jr. E.M. Concurrent chemoradiation is now the standard of care for intermediate-and advanced-stage laryngeal cancer. Head Neck 28 (2006) 1058-1060